Inogen Q2 Adj EPS $(0.25) Beats $(0.64) Estimate, Sales $83.64M Miss $93.27M Estimate
Portfolio Pulse from bharat@benzinga.com
Inogen (NASDAQ:INGN) reported Q2 losses of $(0.25) per share, beating the analyst consensus estimate of $(0.64) by 60.94%. However, the company's quarterly sales of $83.64 million missed the analyst consensus estimate of $93.27 million by 10.33%. This represents a 1150% increase in losses and a 19.10% decrease in sales compared to the same period last year.
August 07, 2023 | 8:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Inogen's Q2 results showed a significant increase in losses but beat analyst estimates. However, sales missed estimates and decreased compared to last year.
Inogen's Q2 results showed a significant increase in losses, which is generally negative for the stock price. However, the losses were less than what analysts had estimated, which could provide some support to the stock. On the other hand, the company's sales missed estimates and decreased compared to the same period last year, which is likely to put downward pressure on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100